On Tuesday, March 02, TherapeuticsMD (NASDAQ:TXMD) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

What Are Earnings, Net Income, And Earnings Per Share?

Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding.

Earnings And Revenue

Based on management's projections, TherapeuticsMD analysts modeled for a loss of $0.1 per share on sales of $21.89 million. In the same quarter last year, TherapeuticsMD announced EPS of $0.19 on revenue of $15.90 million.

What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?

If the company were to post earnings in line with the consensus estimate when it reports Tuesday, EPS would be up 47.37%. Sales would be up 37.66% on a year-over-year basis. TherapeuticsMD's reported EPS has stacked up against analyst estimates in the past like this:

Stock Performance

Shares of TherapeuticsMD were trading at $1.52 as of February 26. Over the last 52-week period, shares are down 4.29%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

Do not be surprised to see the stock move on comments made during its conference call. TherapeuticsMD is scheduled to hold the call at 08:30:00 ET and can be accessed here.